Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
04/2001
04/24/2001CA2220055C Dipeptides which promote release of growth hormone
04/19/2001WO2001027074A1 Preparation of amino-protected lysine derivatives
04/19/2001WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
04/19/2001WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/19/2001CA2386998A1 Preparation of amino-protected lysine derivatives
04/18/2001EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/18/2001CN1291975A Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
04/17/2001US6218551 N-(allyloxycarbonyl)proline derivatives
04/17/2001US6218550 Intermediates useful for the manufacture of carbapenem and a stereoselective manufacturing method therefor
04/17/2001US6218549 Bicyclic aminoimidazoles
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/17/2001US6218424 Heterocyclic ketone and thioester compounds and uses
04/17/2001US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal
04/17/2001US6218417 Ace-inhibitor nitric salts
04/17/2001US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices
04/17/2001US6217845 Protein labelling
04/17/2001CA2220018C Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
04/17/2001CA2182258C Sodium enalapril complex and the use thereof to make sodium enalapril
04/17/2001CA2158457C Naphthalene derivatives
04/17/2001CA2064473C Chimeric amino acids and peptides containing these analogues
04/12/2001WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
04/12/2001WO2001025197A1 Antifungal enediynes
04/12/2001WO2001025172A1 A method for preparing and screening one or more compounds
04/12/2001WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2
04/12/2001DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke
04/12/2001CA2385715A1 A method for preparing and screening one or more compounds
04/11/2001EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient
04/11/2001EP1090008A1 Syntheses of a variety of lamellarin compounds and analogues
04/11/2001EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion
04/11/2001EP1089967A1 Novel compounds useful in pain management
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
04/11/2001CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
04/11/2001CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives
04/10/2001US6215016 Hematopoietic agents; preventing cytopenia
04/10/2001US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders
04/10/2001US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease
04/10/2001US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof
04/10/2001US6214862 Analyzing proteasome sensitivity proteolysis
04/10/2001US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/10/2001US6214610 Process for the preparation of optically active N-benzyl-3-pyrrolidinol
04/10/2001US6214330 Polymeric-based double prodrugs having reversible linkages involving amino or hydroxyl moieties of chemical compounds and biologically active materials such as enzymes and proteins
04/10/2001CA2133413C Indole derivatives as 5-ht1 antagonists
04/05/2001WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
04/05/2001WO2000052012A8 A method for synthesizing porphyrin compounds
04/04/2001EP1088825A1 Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
04/04/2001EP1087935A1 Anthracene derivatives as anti-cancer agents
04/04/2001EP1087934A1 Aminocyclohexyl ether compounds and uses thereof
04/04/2001EP1087763A1 Neurotrophic difluoroamide agents
04/04/2001EP1087663A2 Caspases and apoptosis
04/04/2001EP1087660A1 Composition for keeping away vermin
04/04/2001EP0876326B1 Process for producing amines from olefins on zeoliths of types ssz-26, ssz-33, cit-1 or mixtures thereof
04/04/2001CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them
04/03/2001US6211395 Enantioselective synthesis of 3-aminopyrrolidines
04/03/2001US6211384 Reacting a first reactant containing an amine group with a second reactant containing an acyl halide group, wherein the reaction takes place in the presence of secondary carboxylic acid
04/03/2001US6211379 Process for preparing heterocyclic compounds
04/03/2001US6211362 Pyrroloazepine compounds
04/03/2001US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
04/03/2001US6211241 Aryl sulfonamides and sulfamide derivatives and uses thereof
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211226 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
04/03/2001US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates
04/03/2001US6211175 Cardiac diseases improving method
04/03/2001US6210941 Methods for the detection and isolation of proteins
03/2001
03/29/2001WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp)
03/29/2001WO2001021586A1 Metallo-organo catalyst for polymerizing unsaturated compounds
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
03/29/2001DE19939707A1 Use of new and known amine compounds for stimulating neuronal activity for treating e.g. Alzheimer's and Parkinson's disease, neuralgias and multiple sclerosis
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/28/2001EP1086946A1 Benzamidine derivative
03/28/2001EP1086083A1 Protease inhibitors
03/28/2001EP1086066A1 Muscarinic receptor antagonists
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085854A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/28/2001CN1289334A Benzothiadiazoles and derivatives
03/28/2001CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
03/28/2001CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/27/2001US6207860 Fluorinating agents, far less potential of violent decomposition and attendant high gaseous by-product evolvement, useful for deoxofluorination of alcohols and ketones,
03/27/2001US6207825 Method for production of pyrrolidinone derivatives
03/27/2001US6207824 Using macroporous cation exchange resin
03/27/2001US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics
03/22/2001WO2001019939A1 Fluorescent maleimides and uses thereof
03/22/2001WO2001019908A2 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture
03/22/2001WO2001019826A2 Triazolopyrimidine derivatives
03/22/2001WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases